NeoChord
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10900 73rd Ave North Ste 101, Maple Grov...Website
www.neochord.comRevenue
$10.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About NeoChord
NeoChord is a privately held medical technology company specializing in the advancement of beating heart mitral valve repair for patients suffering from mitral valve regurgitation. Their flagship product, the NeoChord Artificial Chordae Delivery System, offers an echo-guided treatment option that restores normal mitral valve function. The company aims to provide innovative solutions that improve procedural control and preserve treatment options for healthcare professionals. NeoChord's products are designed for use in various clinical settings, targeting both patients and healthcare providers.Explore more
NeoChord Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeoChord your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NeoChord launches new products
Check out if NeoChord is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NeoChord
Funding: Get notified immidiatlly once NeoChord has new funding data
Earning: See what the market has to say on NeoChord recently announced quarterly report
Click to see if NeoChord had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NeoChord, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if NeoChord has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at NeoChord
Find more new buyers
Compare Similar Companies to NeoChord
Compare insights from companies similar to NeoChord, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeoChord is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeoChord is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeoChord.
NeoChord financials insights
Gather financial insights about NeoChord, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series A
$3.4M
2013
Series B
$6M
Debt
$3M
2015
Series C
$20M
2017
Debt
$4M
2018
Series D
$32M
NeoChord Tech Stack
A closer look at the technologies used by NeoChord
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Board of Directors
Funding
, a medical technology company, recently secured $7 million in additional Series D funding from Strategic Healthcare Investment Partners.
Funding
Executive Move
Partnership, Board of Directors
NeoChord News & Media
NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
MINNEAPOLIS, Feb. 22, 2024 /PRNewswire/ -- NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company appointed Todd Berg as Chief Executive Officer to oversee...NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
MINNEAPOLIS, Feb. 22, 2024 /PRNewswire/ -- NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company appointed Todd Berg as Chief Executive Officer to oversee...NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study (EFS) of the NeoChord Transcatheter NeXuS System, a transformational device for mitral chordal repair. In his role, Dr. Leon will be responsible for overseNeoChord Announces Positive 30-day Results with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced positive 30-day results following the first successful worldwide procedure using multiple chords to a single anchor. The procedure was completed with the NeoChord Transcatheter NeXuS System, a transformational device for mitral chordal repair, and the resul
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeoChord
Sign Up For FreeTo access detailed company insights
NeoChord is a privately held medical technology company specializing in the advancement of beating heart mitral valve repair for patients suffering from mitral valve regurgitation. Their flagship product, the NeoChord Artificial Chordae Delivery System, offers an echo-guided treatment option that restores normal mitral valve function. The company a... Read More
